IN2013MU01224A - - Google Patents
Info
- Publication number
- IN2013MU01224A IN2013MU01224A IN1224MU2013A IN2013MU01224A IN 2013MU01224 A IN2013MU01224 A IN 2013MU01224A IN 1224MU2013 A IN1224MU2013 A IN 1224MU2013A IN 2013MU01224 A IN2013MU01224 A IN 2013MU01224A
- Authority
- IN
- India
- Prior art keywords
- compositions
- sitagliptin
- metformin
- salts
- present
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14722341.6A EP2996680A1 (fr) | 2013-03-28 | 2014-03-24 | Compositions pharmaceutiques orales solides comprenant une combinaison de doses fixes de metformine et de sitagliptine ou de leurs sels |
IN1224MU2013 IN2013MU01224A (fr) | 2013-03-28 | 2014-03-24 | |
PCT/IB2014/060081 WO2014170770A1 (fr) | 2013-03-28 | 2014-03-24 | Compositions pharmaceutiques orales solides comprenant une combinaison de doses fixes de metformine et de sitagliptine ou de leurs sels |
US14/766,939 US20150366863A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
ZA2015/05916A ZA201505916B (en) | 2013-03-28 | 2015-08-17 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1224MU2013 IN2013MU01224A (fr) | 2013-03-28 | 2014-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01224A true IN2013MU01224A (fr) | 2015-04-17 |
Family
ID=54395595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1224MU2013 IN2013MU01224A (fr) | 2013-03-28 | 2014-03-24 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU01224A (fr) |
-
2014
- 2014-03-24 IN IN1224MU2013 patent/IN2013MU01224A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021550792A1 (en) | 2-(morpholin-4-yl)-1,7-naphthyridines | |
PH12016501581A1 (en) | Benzimidazol-2-amines as midh1 inhibitors | |
PH12015502615B1 (en) | Chemical compounds | |
PH12016501807A1 (en) | Novel compounds | |
TN2017000258A1 (en) | Pyrazolopyridinamines as mknk1 and mknk2 inhibitors | |
PH12016500054A1 (en) | Substituted pyrazolo-pyridinamines | |
MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
BR112017004580A2 (pt) | composto, composição farmacêutica, produto de combinação, uso de um composto ou sal farmaceuticamente aceitável, e, método de tratamento. | |
PH12016501814A1 (en) | Inhibitors of the wnt signalling pathways | |
PH12014502065A1 (en) | Vesicular formulations | |
GEP201706614B (en) | Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process | |
GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
MX2016014261A (es) | Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis. | |
IN2013MU03428A (fr) | ||
IN2013MU01224A (fr) | ||
IN2013MU01222A (fr) | ||
IN2013MU01225A (fr) | ||
IN2013MU01223A (fr) | ||
PH12015501179A1 (en) | Fixed dose pharmaceutical composition comprising mometasone and azelastine | |
MX2016003763A (es) | Terapia de combinacion con laquinimod para tratamiento de esclerosis multiple. | |
IN2013MU03427A (fr) | ||
IN2014DN10683A (fr) | ||
IN2013MU01158A (fr) | ||
IN2013MU01159A (fr) | ||
MA39762A (fr) | Nouveaux composés |